Anonymous User
Login / Registration

Gastroenterologie
a hepatologie

Gastroenterology and Hepatology

Čes a Slov Gastroent a Hepatol 2010; 64(3): 18-23.

Gastroprotection in long-term use of non-steroidal antirheumatic drugs and low-dose acetylosalicylic acid

Marián Bátovský Orcid.org  1

+ Affiliation

Summary

Summary

The incidence of non-steroidal anti-inflammatory drug /NSA/-related and low-dose acetylosalicylic acid /LD-ASA/-related ulcer complications remains high despite the availability of potent anti-ulcer drugs and selective cyclo-oxygenase-2 inhibitors. These complications can be minimized by a prospective assessment of the patient´s baseline risk, rational choice and use of NSA drugs and selective use of a co-therapy strategy with gastroprotectives. The presence of H. pylori infection significantly increases the risk of upper gastrointestinal complications in NSA drug users, suggesting that all patients requiring regular long-term NSA/LS-ASA drug therapy should be tested for H. pylori.

Keywords

Helicobacter pylori, proton pump inhibitors

To read this article in full, please register for free on this website.

Benefits for subscribers

Benefits for logged users

Credited self-teaching test